An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasWilliam D. Travis, Dominique Valeyre, Cory M. Hogaboam et al.|American Journal of Respiratory and Critical Care Medicine|2013Cited by 4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineGanesh Raghu, Kevin C. Wilson, Martine Rémy‐Jardin et al.|American Journal of Respiratory and Critical Care Medicine|2018Cited by 4.1k
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R. Flaherty, Kevin K. Brown, Athol U. Wells et al.|New England Journal of Medicine|2019Cited by 2.3k
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner SocietyHiroto Hatabu, David A. Lynch, Gary M. Hunninghake et al.|The Lancet Respiratory Medicine|2020Cited by 575
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trialAthol U. Wells, Daniel F. Dilling, Kevin R. Flaherty et al.|The Lancet Respiratory Medicine|2020Cited by 558